Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve The unaudited financial results ....
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs has informed the stock exchanges that its Board of Directors will meet on August 12, 2025 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26), along with the auditors' limited review reports. The filing is made under SEBI Listing Regulations (Regulation 29). The trading window for insiders has been closed since July 1, 2025 and will remain closed until August 14, 2025. No financial figures have been disclosed in this intimation.
This is a routine procedural filing ahead of the Q1 earnings announcement and does not, by itself, carry any direct impact on the stock price. Investors should watch for the actual results on or after August 12, 2025 for any meaningful signals on revenue, margins, or profitability.